{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T21:31:48Z","timestamp":1774128708241,"version":"3.50.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To evaluate the prevalence of novel candidate autoantibodies associated with Sj\u00f6gren syndrome (SS) and their ability to identify those with SS among participants with dry eye enrolled in the Sj\u00f6gren's International Collaborative Clinical Alliance (SICCA) study at the University of Pennsylvania (Penn).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>All participants previously underwent a full ocular and systemic evaluation for possible SS as part of the SICCA study. An enzyme-linked immunosorbent assay was used to detect IgG, IgA, and IgM autoantibodies to salivary protein 1 (SP-1), parotid secretory protein (PSP), and carbonic anhydrase 6 from previously banked baseline serum samples from SICCA study participants enrolled at Penn. The prevalence rate of each autoantibody, calculated by considering the presence of any isotype as antibody positive, was compared between participants with dry eye with SS (n = 81) or without SS (n = 129) using the Fisher exact test.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The prevalence of SP-1 IgM autoantibodies was higher in those with SS compared with those without SS (14% vs. 5%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.03). Similarly, the prevalence of PSP IgA autoantibodies was higher in those with SS compared with non-SS dry eye participants (21% vs. 11%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.048). There was no statistically significant difference in the prevalence of carbonic anhydrase 6 autoantibodies between those with or without SS (15% vs. 20%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.36).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In the Penn SICCA cohort, SP-1 IgM and PSP IgA autoantibodies were more prevalent in the serum of SS-related dry eye participants compared with those without SS. Further longitudinal studies are needed to determine the clinical significance of these findings.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ico.0000000000002147","type":"journal-article","created":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T02:05:10Z","timestamp":1568340310000},"page":"1500-1505","source":"Crossref","is-referenced-by-count":13,"title":["Prevalence of Novel Candidate Sj\u00f6gren Syndrome Autoantibodies in the Penn Sj\u00f6gren's International Collaborative Clinical Alliance Cohort"],"prefix":"10.1097","volume":"38","author":[{"given":"Vatinee Y.","family":"Bunya","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Massaro-Giordano","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick B.","family":"Vivino","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen G.","family":"Maguire","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan N.","family":"Baer","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Gonzales","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA;"},{"name":"Department of Ophthalmology, University of California, San Francisco, San Francisco, California."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gui-shuang","family":"Ying","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,9,10]]},"reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1136\/bjophthalmol-2012-301767","article-title":"Prevalence and predictors of Sjogren's syndrome in a prospective cohort of patients with aqueous-deficient dry eye","volume":"96","author":"Liew","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archinte.164.12.1275","article-title":"Clinical manifestations and early diagnosis of Sj\u00f6gren syndrome","volume":"164","author":"Kassan","year":"2004","journal-title":"Arch Intern Med"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23177","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I","volume":"58","author":"Helmick","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R4-20230912","first-page":"465","article-title":"Diagnosis and management of Sj\u00f6gren syndrome","volume":"79","author":"Kruszka","year":"2009","journal-title":"Am Fam Physician"},{"key":"R5-20230912","first-page":"8","article-title":"Primary Sj\u00f6gren's syndrome: diagnostic criteria, clinical features, and disease activity","volume":"50","author":"Manthorpe","year":"1997","journal-title":"J Rheumatol Suppl"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/annrheumdis-2013-204653","article-title":"Abatacept treatment reduces disease activity in early primary Sj\u00f6gren's syndrome (open-label proof of concept ASAP study)","volume":"73","author":"Meiners","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.14219\/jada.archive.2008.0101","article-title":"Oral involvement in primary Sj\u00f6gren syndrome","volume":"139","author":"Fox","year":"2008","journal-title":"J Am Dent Assoc"},{"key":"R8-20230912","first-page":"125","article-title":"Primary Sjogren's syndrome: clinical spectrum and mode of presentation based on an analysis of 50 patients selected from a department of rheumatology","volume":"40","author":"Markusse","year":"1992","journal-title":"Neth J Med"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ophtha.2014.07.026","article-title":"Ocular and systemic morbidity in a longitudinal cohort of Sjogren's syndrome","volume":"122","author":"Breedveld","year":"2015","journal-title":"Ophthalmology"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.rdc.2016.03.002","article-title":"Autoantibodies in Sj\u00f6gren's syndrome","volume":"42","author":"Fayyaz","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.autrev.2010.09.001","article-title":"The meaning of anti-Ro and anti-La antibodies in primary Sjogren's syndrome","volume":"10","author":"Hernandez-Molina","year":"2011","journal-title":"Autoimmun Rev"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000024423","article-title":"Sj\u00f6gren's syndrome: autoantibodies to cellular antigens. Clinical and molecular aspects","volume":"123","author":"Mavragani","year":"2000","journal-title":"Int Arch Allergy Immunol"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.clim.2012.09.013","article-title":"Novel autoantibodies in Sjogren's syndrome","volume":"145","author":"Shen","year":"2012","journal-title":"Clin Immunol."},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2147\/OPTH.S106973","article-title":"Characterization of the serological biomarkers associated with Sj\u00f6gren's syndrome in patients with recalcitrant dry eye disease","volume":"10","author":"Matossian","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"R15-20230912","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12886-017-0412-8","article-title":"Analysis of novel Sjogren's syndrome autoantibodies in patients with dry eyes","volume":"17","author":"Everett","year":"2017","journal-title":"BMC Ophthalmol"},{"key":"R16-20230912","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2174\/1874312901711010010","article-title":"Evaluation of autoantibodies in patients with primary and secondary Sjogren's syndrome","volume":"11","author":"De Langhe","year":"2017","journal-title":"Open Rheumatol J"},{"key":"R17-20230912","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12886-015-0023-1","article-title":"Investigation of novel autoantibodies in Sjogren's syndrome utilizing Sera from the Sjogren's international collaborative clinical alliance cohort","volume":"15","author":"Suresh","year":"2015","journal-title":"BMC Ophthalmol"},{"key":"R18-20230912","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.clim.2014.08.009","article-title":"Evaluation of salivary gland protein 1 antibodies in patients with primary and secondary Sjogren's syndrome","volume":"155","author":"Shen","year":"2014","journal-title":"Clin Immunol"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/ICO.0000000000001471","article-title":"Utility of novel autoantibodies in the diagnosis of Sj\u00f6gren's syndrome among patients with dry eye","volume":"37","author":"Karakus","year":"2018","journal-title":"Cornea"},{"key":"R20-20230912","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/art.24397","article-title":"An early view of the international Sj\u00f6gren's syndrome registry","volume":"61","author":"Daniels","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R21-20230912","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/acr.21591","article-title":"American college of rheumatology classification criteria for Sj\u00f6gren's syndrome: a data-driven, expert consensus approach in the Sj\u00f6gren's international collaborative clinical alliance cohort","volume":"64","author":"Shiboski","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R22-20230912","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ajo.2009.09.013","article-title":"A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sj\u00f6gren's syndrome international registry","volume":"149","author":"Whitcher","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"R23-20230912","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/acr.23264","article-title":"Natural history and predictors of progression to Sjogren's syndrome among participants of the Sjogren's international collaborative clinical alliance registry","volume":"70","author":"Shiboski","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R24-20230912","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/acr.21610","article-title":"Primary Sjogren's syndrome as a systemic disease: a study of participants enrolled in an international Sjogren's syndrome registry","volume":"64","author":"Malladi","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R25-20230912","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/ICO.0000000000001714","article-title":"Prevalence of novel candidate Sjogren syndrome autoantibodies in the dry eye assessment and management (DREAM) study","volume":"37","author":"Bunya","year":"2018","journal-title":"Cornea"},{"key":"R26-20230912","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/MBC.0000000000000599","article-title":"Novel enzyme immunoassay system for simultaneous detection of six subclasses of antiphospholipid antibodies for differential diagnosis of antiphospholipid syndrome","volume":"28","author":"Nojima","year":"2017","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R27-20230912","doi-asserted-by":"crossref","first-page":"7935451","DOI":"10.1155\/2019\/7935451","article-title":"Clinical correlations of novel autoantibodies in patients with dry eye","volume":"2019","author":"Karakus","year":"2019","journal-title":"J Immunol Res"},{"key":"R28-20230912","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1001\/archopht.121.10.1364","article-title":"Evaluation of the clinical course of dry eye syndrome","volume":"121","author":"Horwath-Winter","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R29-20230912","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/bjo.81.6.435","article-title":"Long-term course of tear gland function in patients with keratoconjunctivitis sicca and Sj\u00f6gren's syndrome","volume":"81","author":"Kruize","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"R30-20230912","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ophtha.2015.10.011","article-title":"Long-term natural history of dry eye disease from the patient's perspective","volume":"123","author":"Lienert","year":"2016","journal-title":"Ophthalmology"},{"key":"R31-20230912","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12886-017-0646-5","article-title":"Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye","volume":"17","author":"McDonnell","year":"2017","journal-title":"BMC Ophthalmol"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0000000000002147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T19:20:47Z","timestamp":1694546447000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0000000000002147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,10]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0000000000002147","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,10]]}}}